March 26, 2020 Update

Below is the Rx-360 Update and Alert for today, March 26, 2020, on COVID-19 information that is relevant to current challenges associated with Supply Chain Integrity and Patient Safety.  Included is information on today’s Town Hall Meeting and a COVID-19 Working Group being hosted by Rx-360.

TODAY: Rx-360 Town Hall Meeting with US Border Patrol Pharmaceutical CEE, Assistant Director, Anthony Orosz.  March 26th at 10:00am EST.  Mr. Orosz will discuss how the US Border Patrol is working through challenges posed by COVID-19 in regard to pharmaceutical supplies being shipped into the United States.  No pre-registration is necessary.  The Town Hall Meeting can be accessed through:

https://zoom.us/j/749390389 Meeting ID: 749 390 389 if needed.

One tap mobile: +19294362866,,749390389# US (New York)  +16699006833,,749390389# US (San Jose)

Dial by your location:  +1 929 436 2866 US (New York)  +1 669 900 6833 US (San Jose) Meeting ID: 749 390 389
Find your local number: https://zoom.us/u/accy9lbrmV

FDA Daily Roundup:

https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-march-25-2020

Additional Items:

US Center for Disease Control and Prevention (CDC) Updates: https://www.cdc.gov/coronavirus/2019-nCoV/index.html

Transported Asset Protection Association (TAPA) Updates: https://www.tapaonline.org/covid-19-toolbox

UK Bans ‘Parallel Exports’ of Key Medicines to ‘Protect Patients’: https://www.export.org.uk/news/496672/UK-bans-parallel-exports-of-key-medicines-to-protect-patients.htm

Rx-360 / COVID-19 Discussion/Working Group:

The Supply Chain Integrity Committee at Rx-360 is requesting volunteers to join a new temporary Rx-360 Working Group around managing risks to the supply chain.  The goal of this working group is to share challenges that we are facing across the industry and using this platform to benchmark those challenges with other companies.  Some opportunities for discussion include:

  • How are companies maintaining supply of goods with borders closures and other restrictions?
  • Given the new and rapidly changing landscape within supply chain, what are best practices and examples of finding reliable suppliers?  Has this been an issue?
  • How are companies maintaining GMP compliance?
  • Do you foresee an increase in supply chain security events, such as theft, un-manifested cargo, counterfeiting, adulteration?

If you or anyone in your organization is interested in joining the group, please respond to myself ([email protected]) or Brittany Doody ([email protected]).  We will be scheduling the initial meeting for April 3rd at 12:00pm EST.

It’s an honor having you involved in Rx-360.  As many of you have expressed, we are part of a great industry that is working hard to end this pandemic.  Thank you very much for that hard work. Feel free to forward this update to anyone in your organization.